Company intelligence / Profile preview

SKNV

Florida, United Statessknv.com ↗

Ownership: Private
Development stage: Other

Overview

SKNV operates an FDA Registered 503B Outsourcing Facility manufacturing over 120 customized dermatology medications. Their products are designed to avoid potentially harmful excipients and allergens found in many branded/generic drugs. They serve over 4,000 providers nationwide with both direct-to-office and direct-to-patient models. Clinical results focus on improved adherence and satisfaction due to tailored formulations; no specific clinical trial data is provided.

Therapeutic areas: DermatologyInfectious Diseases
Modalities: Small moleculeTopical formulation
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on SKNV.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SKNV.

Explore the full profile